Ozempic vs Wegovy: Same Drug, Different Label, Different Price
Both are semaglutide from the same manufacturer. They are not interchangeable products, and only one of them is approved for weight loss.
The short answer#
The differences that matter#
| Ozempic | Wegovy | |
|---|---|---|
| FDA approval | Type 2 diabetes; cardiovascular risk reduction in T2D | Chronic weight management; cardiovascular risk reduction in overweight/obesity |
| Approved for weight loss? | No | Yes |
| Forms | Pen and oral tablet | Pen and oral tablet |
| Cash price (manufacturer) | $349/mo up to 1 mg; $499 at 2 mg; oral from $149 | $349/mo pen; oral from $149 |
| Medicare Bridge ($50 copay) | Not included for weight loss | Included |
| Our tools | Deliberately excluded from weight-loss steering | Included |
Cheapest channels for each, right now#
Sources#
Run your own numbers with the GLP-1 cost calculator, check whether you're overpaying with the price checker, or see every comparison we publish.
Common questions#
Ozempic vs Wegovy?#
If you are researching weight loss, the answer is Wegovy — it is the semaglutide product approved for chronic weight management, and it is what our weight-loss tools point to. Ozempic is approved for type 2 diabetes. The famous weight change in its diabetes trials is real, but an approval is not a rumour, and prescribing decisions belong with a clinician.
Comparisons of approved uses, mechanisms, and published trial averages — not medical advice, and averages are not individuals. Which medication suits you is a decision for you and a licensed clinician. Prices carry the verification dates shown. No link on this page earns us a commission; comparisons are computed from data, never compensation — disclosure.